Financial statements
Consolidated operations, cash flows, and changes in partners capital
Statement of assets, liabilities and partners' capital
Balance sheet — as of 2026-10-05
YTD 2026 as of 2026-10-05 | |
|---|---|
| Assets | |
| 1000 · Cash | $1,167,800.00 |
| 1100-a67954cb · Investment — NovaTech | $3,000,000.00 |
| 1100-b4870bad · Investment — RouteWise | $3,400,000.00 |
| 1100-d08a27bc · Investment — AdVantage | $2,000,000.00 |
| 1100-d4fef540 · Investment — GreenLeaf Bio | $750,000.00 |
| 1200-a67954cb · Unrealized — NovaTech | $3,250,000.00 |
| 1200-b4870bad · Unrealized — RouteWise | $9,763,087.50 |
| 1200-d08a27bc · Unrealized — AdVantage | $1,000,000.00 |
| 1200-d4fef540 · Unrealized — GreenLeaf Bio | $247,500.00 |
| Total Assets | $24,578,387.50 |
| Liabilities | |
| 2100 · Due to GP | $60,000.00 |
| Total Liabilities | $60,000.00 |
| Total Partners' capital | $24,518,387.50 |
$827,800.00 of net income is not yet allocated to partners. Close the period to allocate it — until then each partner’s capital account understates their NAV.
Statement of operations
Income statement — for YTD 2026
YTD 2026 YTD 2026 | |
|---|---|
| Income | |
| 4100 · Interest income | $6,200.00 |
| 4200 · Change in unrealized appreciation | $975,000.00 |
| Total Income | $981,200.00 |
| Expenses | |
| 5000 · Management fee | $120,000.00 |
| 5100 · Partnership expenses | $33,400.00 |
| Total Expenses | $153,400.00 |
| Net income | $827,800.00 |
Statement of cash flows
for YTD 2026
YTD 2026 YTD 2026 | |
|---|---|
| Operating activities | |
| 1100-a67954cb · Investment — NovaTech | -$1,000,000.00 |
| 2100 · Due to GP | -$60,000.00 |
| 4100 · Interest income | $6,200.00 |
| 5100 · Partnership expenses | -$33,400.00 |
| Total Operating activities | -$1,087,200.00 |
| Financing activities | |
| 3100 · Partners' capital | $1,200,000.00 |
| Total Financing activities | $1,200,000.00 |
| Net change in cash | $112,800.00 |
| Opening cash | $1,055,000.00 |
| Ending cash | $1,167,800.00 |
Supplemental — non-cash investing and financing activities
Transactions that changed investments, borrowings, or partners’ capital without moving cash, so they do not appear above.
| 2026-03-31Management fee accrued — quarter ended 2026-03-31 Dr Management fee · Cr Due to GP | $60,000.00 |
| 2026-06-30Management fee accrued — quarter ended 2026-06-30 Dr Management fee · Cr Due to GP | $60,000.00 |
Statement of changes in partners' capital
for YTD 2026 — beginning capital is the balance carried into the period; this is the detail behind the single partners' capital line on the balance sheet
| Partner | Beginning | Contributions | Distributions | Mgmt fees | Partnership exp. | Operating income | Net realized G/(L) | Net unrealized G/(L) | Transfers | Carry accrued | Unclassified | Ending |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coastal University Endowment | $4,685,539.09 | $250,000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4,935,539.09 |
| Hemrock Angels Aggregator I LP | $1,874,215.60 | $100,000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1,974,215.60 |
| Hemrock Founders Capital LP | $7,496,862.49 | $400,000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7,896,862.49 |
| Northstar Family Office I LLC | $5,622,646.88 | $300,000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5,922,646.88 |
| Pinecrest Foundation Charitable Trust | $2,811,323.44 | $150,000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2,961,323.44 |
| Total | $22,490,587.50 | $1,200,000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $23,690,587.50 |